coagulopathy Clinical Trials

16 recruitingLast updated: May 21, 2026

There are 16 actively recruiting coagulopathy clinical trials across 15 countries. Studies span Phase 1, Not Applicable, Phase 3, Phase 4. Top locations include Rotterdam, South Holland, Netherlands, Guangzhou, Guangdong, China, Auckland, Aukland, New Zealand. Updated daily from ClinicalTrials.gov.


coagulopathy Trials at a Glance

16 actively recruiting trials for coagulopathy are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Phase 1 with 2 trials, with the heaviest enrollment activity in Rotterdam, Guangzhou, and Auckland. Lead sponsors running coagulopathy studies include Nanfang Hospital, Southern Medical University, Bayer, and Australian and New Zealand Intensive Care Research Centre.

Browse coagulopathy trials by phase

About coagulopathy Clinical Trials

Looking for clinical trials for coagulopathy? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new coagulopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about coagulopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Phase 1

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

coagulopathySepsis
Bayer36 enrolled20 locationsNCT06854640
Recruiting

Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department

Trauma Induced CoagulopathyTrauma CoagulopathyFibrinogen Deficiency+3 more
Erasmus Medical Center150 enrolled1 locationNCT07097337
Recruiting
Phase 3

Fibrinogen Early In Severe Trauma StudY II

coagulopathyTraumaHaemorrhagic Shock
Australian and New Zealand Intensive Care Research Centre900 enrolled24 locationsNCT05449834
Recruiting

Sepsis-associated Thrombocytopenia and Platelet Transfusion (STAPT)

SepsisSepsis and Coagulopathy
Nanfang Hospital, Southern Medical University1,500 enrolled1 locationNCT07230067
Recruiting

Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock

Trauma CoagulopathyHaemorrhagic Shock
Medical University of Graz10 enrolled1 locationNCT06891131
Recruiting
Not Applicable

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

coagulopathy
Indiana University125 enrolled1 locationNCT05874843
Recruiting

Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.

Hemorrhagic DisordersExtrinsic Pathway Factor DeficiencyHepatocellular Insufficiency With Coagulopathy
University Hospital, Strasbourg, France100 enrolled1 locationNCT06705829
Recruiting

Assessment of Artificial Intelligence Algorithms for ROTEM

coagulopathy
Ondokuz Mayıs University144 enrolled2 locationsNCT07043556
Recruiting

Predictive Accuracy of PLR and PNR in Detecting ETIC

coagulopathyTrauma Injury
Jubilee Mission Medical College and Research Institute250 enrolled1 locationNCT07046858
Recruiting

ROTEM in Sepsis Trauma Outcome in Intensive Care

Sepsis - to Reduce Mortality in the Intensive Care UnitTrauma Coagulopathy
Region Stockholm600 enrolled1 locationNCT06891599
Recruiting

Patient Blood Management Implementation in CEE Study

coagulopathyAnemia
Semmelweis University2,000 enrolled1 locationNCT06878105
Recruiting
Phase 4

Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography

Trauma Coagulopathy
Nanfang Hospital, Southern Medical University580 enrolled1 locationNCT06736860
Recruiting

Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Ischemic StrokeOccult CancerCancer-related Stroke+3 more
Insel Gruppe AG, University Hospital Bern370 enrolled3 locationsNCT06100718
Recruiting
Phase 1

A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

COVID 19 Associated Coagulopathy
Westlake University80 enrolled1 locationNCT06355258
Recruiting

Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana

coagulopathyThrombiHemorrhage+1 more
University Hospital Center of Martinique30 enrolled1 locationNCT06304714
Recruiting

Dynamic changes in clot formation using Thromboelastometry after reinfusion of unwashed cell salvaged whole blood in total hip arthroplasty: a pilot study

coagulopathyclot formationshed blood+1 more
Astra Tech AB25 enrolled1 locationACTRN12612000691842